Why Content Management Systems Matter for Clinical Trials

The process of taking a product through a new clinical trial is lengthy and detailed. Researchers and teams of scientists not only must be very critical and methodical about the ways in which they test new drugs and cures, but they also must be meticulous about how they document their processes. Every detail counts when it is time for the approval process performed by the Food and Drug Administration. New pharmaceutical treatments are heavily regulated and must undergo many levels of approval before they are released to the world market.

How do researchers keep up with the many report versions and documentation of their development processes? They need a content management system that makes it easier. Systems that hold this kind of confidential and proprietary information do not necessarily take the place of paper with authentic signatures. However, it does make it easier to control documents and track the changes that happen in the process of new drug development. Clinical trial data is edited, reviewed and approved often, and every member of a team should know who makes changes to the data and why. High level organization like this helps to ensure a much less cumbersome approval process with the FDA.

Companies that cannot take advantage of any kind of content management platform service are often at a disadvantage. They rely solely on paper and risk data compromise, damage or destruction to documents and inaccuracy in recording and reporting data. Because the clinical trial registration process already takes years to get through, content management should be a necessity for every company that has to obtain approval.